eIF4E/4E-BP Ratio Predicts the Efficacy of mTOR Targeted Therapies
Abstract Active-site mTOR inhibitors (asTORi) hold great promise for targeting dysregulated mTOR signaling in cancer. Because of the multifaceted nature of mTORC1 signaling, ide...
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 1
- Citations
- 159
- Institution
- Jewish General Hospital
External Links
Identifiers
- ORCID
- 0000-0002-8627-084X
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.